Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000349
Filing Date
2025-04-25
Accepted
2025-04-25 16:43:09
Documents
42
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q restez10q093024.htm   iXBRL 10-Q 312982
2 EXHIBIT 31-1 restezex31-1.htm EX-31.1 12874
3 EXHIBIT 31-2 restezex31-2.htm EX-31.2 12607
4 EXHIBIT 32-1 restezex32-1.htm EX-32.1 6529
5 EXHIBIT 32-2 restezex32-2.htm EX-32.2 7278
  Complete submission text file 0001185185-25-000349.txt   1766584

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rest-20240930.xsd EX-101.SCH 14064
7 XBRL CALCULATION FILE rest-20240930_cal.xml EX-101.CAL 13897
8 XBRL DEFINITION FILE rest-20240930_def.xml EX-101.DEF 52661
9 XBRL LABEL FILE rest-20240930_lab.xml EX-101.LAB 108457
10 XBRL PRESENTATION FILE rest-20240930_pre.xml EX-101.PRE 64182
45 EXTRACTED XBRL INSTANCE DOCUMENT restez10q093024_htm.xml XML 102081
Mailing Address 1398 WEST MASON HOLLOW DRIVE RIVERTON UT 84065
Business Address 1398 WEST MASON HOLLOW DRIVE RIVERTON UT 84065 801-300-2542
REST EZ Inc. (Filer) CIK: 0001733861 (see all company filings)

EIN.: 824268982 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56447 | Film No.: 25874833
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)